Literature DB >> 6732015

Bovine coccidiosis: protective effects of low-level infection and coccidiostat treatments in calves.

G Conlogue, W J Foreyt, R B Wescott.   

Abstract

Twenty coccidia-free Holstein bull calves were allotted to groups to study effects of treatment with lasalocid and decoquinate on subsequent resistance to coccidiosis (Eimeria spp infections). Calves fed medicated rations of either drug at dosages of 50 mg/kg of feed (approx 1.2 mg/kg of body weight) had significantly fewer oocysts (P less than 0.01) than did nontreated controls regardless of other procedures used. Treated calves premunized with 2,000 oocysts/day for 5 days and later challenge inoculated with 200,000 oocysts did not develop diarrhea, unless the drugs were withdrawn from feed. Animals premunized (2,000 oocysts/day for 5 days) in absence of drug were no more resistant to the challenge inoculation than nonpremunized animals. These results indicated that lasalocid and decoquinate were efficacious coccidiostats and protected calves as long as they were administered. Cessation of drug treatment usually resulted in appearance of oocysts in feces and diarrhea. Premunization alone cannot be expected to prevent coccidiosis when animals are exposed to large numbers of oocysts.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6732015

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  2 in total

1.  Control strategies using diclazuril against coccidiosis in goat kids.

Authors:  Antonio Ruiz; Aránzazu C Guedes; María C Muñoz; José M Molina; Carlos Hermosilla; Sergio Martín; Yeray I Hernández; Alvaro Hernández; Davinia Pérez; Lorena Matos; Adassa M López; Anja Taubert
Journal:  Parasitol Res       Date:  2011-12-23       Impact factor: 2.289

Review 2.  Eimeria infections in domestic and wild ruminants with reference to control options in domestic ruminants.

Authors:  Berit Bangoura; Md Ashraful Islam Bhuiya; Michelle Kilpatrick
Journal:  Parasitol Res       Date:  2022-06-10       Impact factor: 2.383

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.